常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.24/-1.62
|
|
企業價值
137.68M
|
| 資產負債 |
|
每股賬面淨值
1.35
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
3.55M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2025/11/16 08:41 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. |

5.87 
